Abstract
Flow focusing technology is known to be advantageous for micro- and nanoparticle production. We investigated the applicability of this technology to produce subsieve-size mammalian cell-enclosing capsules of less than 100 μm in diameter. Subsieve-size capsules with a narrow size distribution were obtained via droplets breakup in a water-immiscible co-flowing liquid flow by a flow focusing process. Compared with the production process of non-flow focusing, the capsules could be prepared with less consumption of the water-immiscible fluid of liquid paraffin. No harmful effects resulting from the flow focusing process on the cells enclosed in the capsules were detected in this study. The undamaged percentage of the cells immediately after the enclosing process was 96.6 ± 1.8%, and the cells enclosed in subsieve-size agarose capsules showed mitochondrial activity for over 3 weeks. These results showed that flow focusing is an effective process for producing cell-enclosing subsieve-size capsules.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
